Global Lipid Nanoparticle Raw Materials Market Size is Projected to Hit USD 333.85 million at a 5.2% CAGR from 2024 to 2032- Report by Polaris Market Research (PMR)

Lipid nanoparticles are acquiring an escalation in demand due to their evolving application in drug advancement ventures. This is because of the massive possibility of conveying the needed medicines to the designated area, causing maximal operating in the illness recuperation procedure.

New York, May 22, 2024 (GLOBE NEWSWIRE) -- Market Overview:

The Global Lipid Nanoparticle Raw Materials Market was valued at USD 211.19 million in 2023 and is anticipated to generate an estimated revenue of USD 333.85 million by 2032, with a CAGR of 5.2% from 2024 to 2032.

Lipid nanoparticles are nanoparticles constituted of lipids. They have been advanced as means for compact molecular conveyance by the nanomedicines, and substance communities are now a main constituent of the COVID-19 mRNA vaccine. Currently, LNP is a proportionately evolved technology platform that can be utilized to convey RNA drugs, vaccines, or gene editing instruments. Lipid nanoparticles are nanoscale paths of management gadgets majorly constituted of lipids.

The rapidly rising demand for the lipid nanoparticle raw materials industry can be attributed to the fact that the nanoparticles offer the basis for capturing and transforming therapeutic materials to specific cells and tissues in the body, such as nucleic acid, peptides, medicines, and bioactive molecules.

Moreover, the lipid nanoparticle raw materials market growth can be attributed to the escalating pervasiveness of generative medicine usage in the healthcare sector. Lipid nanoparticles play an impactful part in tissue engineering procedures as they need conveyance agents. Additionally, the escalating steps to improve their product line are disposed to strengthen the demand in the upcoming years. For instance, in June 2023, Bayer AG embarked upon an alliance structure with Acuitas Therapeutics, Inc. to augment its gene therapy commodity contribution with lipid nanoparticle technology.

Download Free Sample PDF Copy of the Report:

Fundamental Stats from the Report:

  • The market for lipid nanoparticle raw materials was valued at USD 211.19 million in 2023.
  • The market is expected to grow at a 5.2% compound annual growth rate (CAGR) from 2024 to 2032.
  • The lipid nanoparticle raw materials market size is anticipated to grow to USD 333.85 million by 2032.

Key Findings from the Report:

  • The market for lipid nanoparticle raw materials is expanding due to the rising demand for materials that advance lipid nanoparticles, such as surfactants, lipids, stabilizers, and polymers.
  • The market is primarily segmented by product, disease indication, application, end-use, and region.
  • North America dominated the market with the largest lipid nanoparticle raw materials market share.

Market Key Players:

  • Avanti Polar Lipids (US)
  • Biopharma PEG Scientific Inc. (US)
  • BroadPharm (US)
  • CordenPharma International (Germany)
  • Creative Biolabs (US)
  • Echelon Biosciences (US)
  • Merck KGaA (Germany)

Request for a Discount on this Report Before Purchase @

Important Market Developments

Growth Drivers:

  • One prominent factor driving the market growth of the lipid nanoparticle raw materials is the mRNA technique, which is changing the way people generate contemporary therapeutics in the worldwide marketplace. Because of its skilled conveyance system, it is broadly engaged in the formation of the COVID-19 vaccine. The continuing inventions in pharmaceutical and biotechnology firms are generating contemporary growth possibilities for lipid nanoparticle raw materials.
  • Also, the lipid nanoparticle raw materials market is anticipated to profit from growing consciousness about the significance of liquid nanoparticles in conveying RNA to needed cells. A 2023 study issued in Nature Biomedical Engineering concentrated on encouraging the immunogenicity of lipid nanoparticle-dependent mRNA vaccines by engineering COVID-19 antigens and nanoparticles.


  • The forecast period will witness a sizeable growth in lipid nanoparticle raw materials market demand mainly due to the evolving research studies. For instance, in October 2023, a study issued in Proceedings of the National Academy of Sciences advanced a contemporary lipid nanoparticle that can function productively in conveying mRNA to the earmarked muscle and restrict astray results.


  • The intricacies linked with the production of lipid nanoparticles are a prominent demand element prohibiting the use of lipid nanoparticle raw materials, which accordingly lessens the demand for raw materials in the study period. The incompetency of conveying the molecules to the pronounced area because of their inherent uncertainty seems to restrict their acquisition, pushed by the significance of a steady bearer system in vaccine advancement.

Inquire more about this report before purchase @

Regional Insights:

North America: The lipid nanoparticle raw materials market in North America is expected to escalate due to the prevalence of distinguished pharmaceutical or biotechnological firms funding notable amounts in drug detection processes.

Asia Pacific: The region is emerging as the fastest growing due to the notable escalation in blood illnesses in the region.

Segmentation Overview:

By Product Outlook

  • Ionizable lipids
  • Reagents
  • Other raw materials

By Disease Indication Outlook

  • Cancer
  • Infectious Diseases
  • Blood Diseases
  • Others

By Application Outlook

  • Therapeutics
  • Research

By Region Outlook

  • North America (U.S., Canada)
  • Europe (France, Germany, UK, Italy, Netherlands, Spain, Russia)
  • Asia Pacific (Japan, China, India, Malaysia, Indonesia. South Korea)
  • Latin America (Brazil, Mexico, Argentina)
  • Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Explore PMR's Related Ongoing Coverage in Chemicals and Material Domain:

About Polaris Market Research:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR’s clientele spread across different enterprises. We at Polaris are obliged to serve PMR’s diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR’s customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR’s customers.

Likhil G
30 Wall Street
8th Floor,
New York City, NY 10005,
United States
Phone: +1-929 297-9727
Follow Us: LinkedIn Twitter